Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Stem cells and spinal cord repair.

Snyder EY, Teng YD.

N Engl J Med. 2012 May 17;366(20):1940-2. doi: 10.1056/NEJMcibr1200138. No abstract available.

PMID:
22591301
2.

Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis.

Teng YD, Benn SC, Kalkanis SN, Shefner JM, Onario RC, Cheng B, Lachyankar MB, Marconi M, Li J, Yu D, Han I, Maragakis NJ, Lládo J, Erkmen K, Redmond DE Jr, Sidman RL, Przedborski S, Rothstein JD, Brown RH Jr, Snyder EY.

Sci Transl Med. 2012 Dec 19;4(165):165ra164. doi: 10.1126/scitranslmed.3004579.

PMID:
23253611
3.

Stem cell heterogeneity: implications for aging and regenerative medicine.

Muller-Sieburg CE, Sieburg HB, Bernitz JM, Cattarossi G.

Blood. 2012 Apr 26;119(17):3900-7. doi: 10.1182/blood-2011-12-376749. Epub 2012 Mar 9. Review.

4.

Three-dimensional scaffolding to investigate neuronal derivatives of human embryonic stem cells.

Soman P, Tobe BTD, Lee JW, Winquist AM, Singec I, Vecchio KS, Snyder EY, Chen S.

Biomed Microdevices. 2012 Oct;14(5):829-838. doi: 10.1007/s10544-012-9662-7.

5.

Phosphoproteomic analysis: an emerging role in deciphering cellular signaling in human embryonic stem cells and their differentiated derivatives.

Tobe BT, Hou J, Crain AM, Singec I, Snyder EY, Brill LM.

Stem Cell Rev. 2012 Mar;8(1):16-31. doi: 10.1007/s12015-011-9317-8. Review.

6.

A bioinformatic assay for pluripotency in human cells.

Müller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP, Danner S, Goldmann JE, Herbst A, Schmidt NO, Aldenhoff JB, Laurent LC, Loring JF.

Nat Methods. 2011 Apr;8(4):315-7. doi: 10.1038/nmeth.1580. Epub 2011 Mar 6.

7.

Identification of human embryonic progenitor cell targeting peptides using phage display.

Bignone PA, Krupa RA, Sternberg H, Funk WD, Snyder EY, West MD, Larocca D.

PLoS One. 2013;8(3):e58200. doi: 10.1371/journal.pone.0058200. Epub 2013 Mar 4.

8.
9.

Deriving dopaminergic neurons for clinical use. A practical approach.

Gonzalez R, Garitaonandia I, Abramihina T, Wambua GK, Ostrowska A, Brock M, Noskov A, Boscolo FS, Craw JS, Laurent LC, Snyder EY, Semechkin RA.

Sci Rep. 2013;3:1463. doi: 10.1038/srep01463.

10.

Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury.

Obenaus A, Dilmac N, Tone B, Tian HR, Hartman R, Digicaylioglu M, Snyder EY, Ashwal S.

Ann Neurol. 2011 Feb;69(2):282-91. doi: 10.1002/ana.22168. Epub 2010 Nov 22.

11.

Overexpression of basic helix-loop-helix transcription factors enhances neuronal differentiation of fetal human neural progenitor cells in various ways.

Serre A, Snyder EY, Mallet J, Buchet D.

Stem Cells Dev. 2012 Mar 1;21(4):539-53. doi: 10.1089/scd.2011.0079. Epub 2011 Jul 18.

12.

Automated core-penumbra quantification in neonatal ischemic brain injury.

Ghosh N, Yuan X, Turenius CI, Tone B, Ambadipudi K, Snyder EY, Obenaus A, Ashwal S.

J Cereb Blood Flow Metab. 2012 Dec;32(12):2161-70. doi: 10.1038/jcbfm.2012.121. Epub 2012 Aug 29.

13.

Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.

Arthur JR, Lee JP, Snyder EY, Seyfried TN.

Neurochem Res. 2012 Jun;37(6):1335-43. doi: 10.1007/s11064-012-0718-0. Epub 2012 Feb 25.

PMID:
22367451
14.

Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell.

Kim KS, Lee HJ, Jeong HS, Li J, Teng YD, Sidman RL, Snyder EY, Kim SU.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4876-81. doi: 10.1073/pnas.1019743108. Epub 2011 Mar 4.

15.

Optical imaging of progenitor cell homing to patient-derived tumors.

Newton IG, Plaisted WC, Messina-Graham S, Abrahamsson Schairer AE, Shih AY, Snyder EY, Jamieson CH, Mattrey RF.

Contrast Media Mol Imaging. 2012 Nov-Dec;7(6):525-36. doi: 10.1002/cmmi.1485.

16.

MMP-3 mediates psychosine-induced globoid cell formation: implications for leukodystrophy pathology.

Ijichi K, Brown GD, Moore CS, Lee JP, Winokur PN, Pagarigan R, Snyder EY, Bongarzone ER, Crocker SJ.

Glia. 2013 May;61(5):765-77. doi: 10.1002/glia.22471. Epub 2013 Feb 13.

17.

Modeling complex neuropsychiatric disorders with human induced pluripotent stem cells.

Tobe BT, Snyder EY, Nye JS.

Curr Opin Pharmacol. 2011 Oct;11(5):521-7. doi: 10.1016/j.coph.2011.05.007. Epub 2011 Jun 29. Review.

18.

The risk of putting something where it does not belong: mesenchymal stem cells produce masses in the brain.

Snyder EY.

Exp Neurol. 2011 Jul;230(1):75-7. doi: 10.1016/j.expneurol.2011.03.012. Epub 2011 Mar 21. No abstract available.

PMID:
21420402
19.

Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.

Kern DS, Maclean KN, Jiang H, Synder EY, Sladek JR Jr, Bjugstad KB.

Cell Transplant. 2011;20(3):371-9. doi: 10.3727/096368910X528085. Epub 2010 Sep 27.

PMID:
20875225
20.

The puzzling origin of lymphocytes.

Muller-Sieburg C.

Blood. 2012 Jun 14;119(24):5609-10. doi: 10.1182/blood-2012-04-420737. No abstract available.

Supplemental Content

Support Center